O
ONKURE THERAPEUTICS, INC.
NASDAQ: OKUR (OnKure Therapeutics, Inc.)
最近更新时间: 5小时之前2.33
-0.05 (-2.10%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | OnKure Therapeutics, Inc. | 混合的 | - |
AIStockmoo 评分
1.2
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 0.5 |
| 技术平均移动指标 | 5.0 |
| 技术振荡指标 | -2.0 |
| 平均 | 1.17 |
|
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 1.57% |
| 机构持股比例 | 98.08% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Cormorant Asset Management, Lp | 31 Mar 2025 | 1,837,739 |
| Acorn Capital Advisors, Llc | 31 Mar 2025 | 1,439,674 |
| Citadel Advisors Llc | 31 Mar 2025 | 1,068,104 |
| Perceptive Advisors Llc | 31 Mar 2025 | 1,004,439 |
| Samsara Biocapital, Llc | 31 Mar 2025 | 824,155 |
| Vestal Point Capital, Lp | 31 Mar 2025 | 635,000 |
| Deep Track Capital, Lp | 31 Mar 2025 | 523,989 |
| Stepstone Group Lp | 31 Mar 2025 | 491,938 |
| Nea Management Company, Llc | 31 Mar 2025 | 478,548 |
| Highbridge Capital Management Llc | 31 Mar 2025 | 438,797 |
| Affinity Asset Advisors, Llc | 31 Mar 2025 | 394,159 |
| Carlyle Group Inc. | 31 Mar 2025 | 269,895 |
| Ikarian Capital, Llc | 31 Mar 2025 | 253,754 |
该时间范围内无数据。
该时间范围内无数据。
| 日期 | 类型 | 细节 |
|---|---|---|
| 06 May 2025 | 公告 | OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合